Thyroid medications affect your kidneys in ways that range from clearly beneficial to occasionally harmful, depending on which medication you’re taking and why. The most commonly prescribed thyroid drug, levothyroxine, generally helps kidney function by correcting the hormonal deficit that was slowing blood flow through the kidneys in the first place. But other thyroid-related treatments, including antithyroid drugs for overactive thyroids and targeted cancer therapies, carry distinct kidney risks that are less widely appreciated.
Why Your Thyroid and Kidneys Are So Closely Linked
Thyroid hormones directly influence how much blood your kidneys receive and how efficiently they filter it. They increase both renal blood flow and the glomerular filtration rate, which is the measure of how well your kidneys clean your blood per minute.1PubMed Central. Interactions between thyroid disorders and kidney disease When thyroid hormone levels drop, filtration slows. When levels are restored, filtration picks back up. This is why nearly every thyroid condition eventually shows up on kidney lab work, and why treating the thyroid problem often fixes abnormal kidney numbers without any kidney-specific treatment at all.
Levothyroxine Tends to Help, Not Harm
If you’re hypothyroid and your doctor prescribes levothyroxine, the evidence strongly suggests your kidneys will benefit. In one study, hypothyroid patients had a mean creatinine of about 2.3 mg/dL before treatment, which dropped to around 0.97 mg/dL afterward, while their estimated filtration rate climbed from roughly 67 to 79 mL/min.2PubMed Central. Thyroid Dysfunction and Renal Function: A Crucial Relationship to Recognize An earlier study found that creatinine levels were about 35% higher during episodes of severe hypothyroidism compared to when the same patients were adequately treated, and those elevations reversed consistently once thyroid levels normalized.3JAMA Internal Medicine. Consistent Reversible Elevations of Serum Creatinine Levels in Severe Hypothyroidism
The kidney benefits extend to people who already have chronic kidney disease. In patients with stage 3 to 4 CKD and hypothyroidism, levothyroxine treatment slowed the decline of kidney function, with the effect being more pronounced in stage 3 disease than stage 4.4PubMed Central. FAVORABLE EFFECT OF LEVOTHYROXINE ON NUTRITIONAL STATUS OF PATIENTS WITH STAGE 3-4 CHRONIC KIDNEY DISEASE Another trial showed that patients with advanced CKD who received levothyroxine gained about 4 mL/min in filtration rate while the placebo group lost about 2 mL/min, and the treated group also had a significant drop in proteinuria.5Kidney International Reports. A Pilot Trial on the Effect of Levothyroxine on Proteinuria in Patients With Advanced CKD In nondiabetic CKD patients with hypothyroidism, six months of thyroid hormone replacement raised their filtration rate from about 14 to 22 mL/min.6PubMed Central. Prevalence of hypothyroidism in nondiabetic chronic kidney disease and effect of thyroxine replacement on estimated glomerular filtration rate
Even in people with subclinical hypothyroidism, where thyroid levels are only mildly off, treatment appears to slow the rate at which kidney function declines over time and improve the odds of staying off dialysis longer.7PubMed Central. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism A review in Mayo Clinic Proceedings reached the same conclusion: thyroid replacement in CKD patients with subclinical hypothyroidism was associated with slower kidney decline and higher renal event-free survival.8Mayo Clinic Proceedings. Thyroid Dysfunction and Chronic Kidney Disease: Association, Causation, and Potential for Therapeutic Intervention
What Happens When Hypothyroidism Goes Untreated
The flip side of “levothyroxine helps your kidneys” is that leaving hypothyroidism untreated can hurt them. Beyond the gradual filtration slowdown, severe hypothyroidism can trigger rhabdomyolysis, a breakdown of muscle tissue that floods the kidneys with a protein called myoglobin. This can cause acute kidney injury, which is a sudden and potentially dangerous drop in kidney function.9PubMed Central. The Significance of Rhabdomyolysis Secondary to Hypothyroidism Case reports describe otherwise healthy people developing rhabdomyolysis from undiagnosed hypothyroidism with no other obvious trigger.10PubMed Central. Severe hypothyroidism‐induced rhabdomyolysis: A case report
In a small retrospective analysis of five patients with this complication, muscle enzymes and kidney function returned to normal after thyroid hormone replacement, though two patients needed temporary dialysis support during recovery.11PubMed Central. Rare acute kidney injury secondary to hypothyroidism-induced rhabdomyolysis This is uncommon, but it underscores why persistent muscle pain, dark urine, and extreme fatigue in someone with untreated or poorly managed hypothyroidism warrant prompt medical attention.
Antithyroid Drugs and a Rare but Serious Kidney Risk
People with overactive thyroids (hyperthyroidism) take the opposite kind of medication: antithyroid drugs like methimazole. These carry their own kidney concern. Methimazole can, in rare cases, trigger a condition called ANCA-associated vasculitis, where the immune system attacks small blood vessels, including those in the kidneys. One reported case involved a woman on methimazole for Graves’ disease who developed severely impaired kidney function with a creatinine of 2.65 mg/dL and a filtration rate of just 20 mL/min. A kidney biopsy showed crescentic glomerulonephritis, an aggressive form of kidney inflammation, caused by the drug.12PubMed Central. Methimazole-Induced ANCA Vasculitis: A Case Report
This is a recognized but rare side effect. If you’re taking methimazole and develop unexplained joint pain, skin rash, blood in your urine, or a new decline in kidney function, it’s worth bringing up with your doctor. Catching it early and stopping the drug typically leads to better outcomes than continuing treatment while the vasculitis progresses.
Radioactive Iodine and Impaired Kidneys
Radioactive iodine (I-131) is used both for overactive thyroids and for thyroid cancer treatment. This form of therapy is mainly cleared through the kidneys, so when kidney function is already reduced, the radioactive iodine sticks around in the body much longer than intended. In healthy people, about 56% of a radioactive iodine dose is excreted within 24 hours. In patients with CKD, only about 11% is eliminated in the same time frame, leading to roughly three and a half times the radiation exposure.13PubMed Central. Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed
That delayed clearance raises the risk of bone marrow toxicity. One study found that patients with a filtration rate below 30 mL/min still retained about a third of their radiation exposure at 48 hours, compared to only about 6% in people with healthy kidneys.14Journal of the Endocrine Society. 8675 Dosing of Radioactive Iodine for Papillary Thyroid Cancer in Advanced Chronic Kidney Disease Dialysis helps but does not fully compensate. In one series, the first dialysis session after radioiodine treatment removed about two-thirds of the remaining whole-body radioactivity, and no significant blood-related toxicity was observed with careful dose management.15Journal of Nuclear Medicine. Management of Patients with Renal Failure Undergoing Dialysis During 131I Therapy for Thyroid Cancer The practical upshot is that radioactive iodine can still be used in people with kidney disease, but the doses typically need to be reduced and the treatment schedule coordinated with dialysis sessions if applicable.
Targeted Cancer Drugs for Thyroid Cancer
A newer concern comes from tyrosine kinase inhibitors (TKIs), drugs used for advanced thyroid cancers that no longer respond to radioactive iodine. These drugs work by blocking blood vessel growth in tumors, but that same mechanism can damage the delicate blood vessels in the kidneys. Proteinuria, where protein leaks into the urine, is the most commonly reported kidney side effect. Across studies, it affects anywhere from about 6% to 34% of patients, with severe proteinuria occurring in roughly 1% to 10%.16PubMed Central. Prevalence and management of proteinuria associated with vascular endothelial growth factor receptor-targeted tyrosine kinase inhibitor treatment in advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer
Among the TKIs used for thyroid cancer, lenvatinib appears to carry the highest kidney risk. Compared to sorafenib, patients on lenvatinib had more proteinuria, lower filtration rates, and lower blood albumin levels.17PubMed Central. Renal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors A retrospective study The kidney damage from TKIs appears to be at least partly reversible when treatment is paused or stopped, but catching it early through routine urine monitoring matters. These drugs have dramatically improved outcomes for patients with aggressive thyroid cancers, so the kidney risk has to be weighed against the benefit of controlling the cancer itself.18PubMed. Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update
Drug Interactions That Can Sneak Up on You
If you have kidney disease and take levothyroxine, the medications you take for your kidneys can interfere with your thyroid treatment. Phosphate binders, which are commonly prescribed for dialysis patients to keep phosphorus levels in check, can block the absorption of levothyroxine in the gut. The interference is strongest with sevelamer, one of the most widely used binders.19PubMed Central. Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature The result is that even though you’re taking your thyroid medication faithfully, your body isn’t absorbing enough of it, and your thyroid levels creep back into the hypothyroid range.20PubMed Central. Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease
Separating the doses by a few hours helps but doesn’t completely eliminate the problem. Taking levothyroxine at bedtime instead of in the morning, or switching to a liquid formulation that absorbs differently, are strategies that may work better for people juggling multiple medications. If your thyroid levels have been stable and then drift off after starting a phosphate binder, the binder is a prime suspect.
Kidney Lab Tests Can Be Misleading in Thyroid Patients
Here’s something that trips up even some doctors: thyroid dysfunction changes the kidney markers themselves, not just actual kidney function. Creatinine, the blood test most commonly used to estimate filtration rate, goes up in hypothyroidism partly because muscle metabolism slows and creatinine clearance drops. When treatment normalizes thyroid levels, creatinine falls. That looks like kidney function “improved,” and to some extent it did, but part of the change is just the marker correcting itself rather than the kidneys dramatically repairing.
Cystatin C, a newer kidney marker sometimes used alongside creatinine, has the opposite problem. It moves in unpredictable ways with thyroid status. In hypothyroid patients whose levothyroxine dose isn’t quite right, cystatin C runs higher even when the actual measured filtration rate is normal. One study found that among the standard kidney markers, cystatin C was far more sensitive to subtle hypothyroidism than creatinine or estimated filtration rate.21PubMed Central. Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy Another cross-sectional study showed that creatinine and cystatin C move in opposite directions depending on whether you’re hyperthyroid or hypothyroid: hyperthyroidism lowered creatinine but raised cystatin C, while hypothyroidism did the reverse.22PubMed. Thyroid function differently affects serum cystatin C and creatinine concentrations
What this means for you: if your kidney numbers look off and you also have a thyroid condition, don’t panic immediately. Make sure your doctor knows about your thyroid status before interpreting those results. A kidney number that looks alarming might be driven more by the thyroid than by actual kidney damage.
Autoimmune Thyroid Disease and the Kidneys
The immune system adds another layer. Autoimmune thyroid diseases like Hashimoto’s thyroiditis and Graves’ disease don’t just affect the thyroid. The same immune dysregulation that attacks the thyroid gland can also target kidney tissue. A study comparing patients who had both autoimmune thyroid disease and kidney disease against those with kidney disease alone found that the autoimmune thyroid group had higher rates of membranous nephropathy and a different overall pattern of kidney pathology.23PubMed Central. Relationship between autoimmune thyroid disease and nephropathy: A clinicopathological study Membranous nephropathy, a condition where the kidney’s filtering membranes thicken and leak protein, has been reported in association with severe hypothyroidism, prompting recommendations that clinicians check thyroid function in anyone with unexplained protein in the urine.24PubMed Central. Membranous nephropathy associated with profound hypothyroidism
This isn’t something thyroid medication causes. It’s something the underlying autoimmune process causes. But it’s relevant because treating the thyroid condition is part of addressing the kidney issue when autoimmunity links the two.
Hypothyroidism and Low Sodium
One easily overlooked kidney-related consequence of hypothyroidism is hyponatremia, or low blood sodium. Thyroid hormones influence how the kidneys handle water, and when levels are low, the kidneys can retain too much water relative to sodium, diluting the bloodstream. Replacing thyroid hormone resolves the hyponatremia in these patients.25PubMed Central. Effect of Optimal Thyroid Replacement Therapy on Chronic Hyponatremia with Focused Review of the Evidence, Mechanisms, and Clinical Implications If you’ve been told you have low sodium and also have thyroid issues, the fix might be getting your thyroid levels right rather than simply restricting water intake.
Children Born With Hypothyroidism
Parents of children diagnosed with congenital hypothyroidism sometimes worry about long-term organ effects, including kidney development. A study measuring kidney size in these children found that while their kidneys were smaller in absolute terms compared to controls, the size was proportional to their body weight and height. Importantly, kidney growth normalized with levothyroxine treatment regardless of whether the medication was started before or after six months of age, and regardless of how severe the hypothyroidism was at diagnosis.26PubMed. Kidney growth in children with congenital hypothyroidism In other words, the kidneys catch up once the hormonal environment is corrected, even if treatment is somewhat delayed.